Immune monitoring for advanced cell therapy trials in transplantation: which assays and when?

Immune monitoring for advanced cell therapy trials in transplantation: which assays and when?

A number of immune regulatory cellular therapies, including regulatory T cells and mesenchymal stromal cells, have emerged as novel alternative therapies for the control of transplant alloresponses. Clinical studies have demonstrated their feasibility and safety, however developing our understanding...

書目詳細資料
Main Authors:	Stark, HL, Wang, HC, Kuburic, J, Alzhrani, A, Hester, J, Issa, F
格式:	Journal article
語言:	English
出版:	Frontiers Media 2021

相似書籍

Immune Monitoring for Advanced Cell Therapy Trials in Transplantation: Which Assays and When?
由: Helen L. Stark, et al.
出版: (2021-03-01)

An exploration of regulatory T cells in transplantation: cell therapy development and immune monitoring
由: Alzhrani, AI
出版: (2021)

Biomarkers and surrogates of acute rejection in vascularized composite allograft transplantation
由: Honeyman, C, et al.
出版: (2021)

Biomarker and surrogate development in vascularised composite allograft transplantation: current progress and future challenges
由: Honeyman, C, et al.
出版: (2020)

Immune Monitoring Assay for Extracorporeal Photopheresis Treatment Optimization After Heart Transplantation
由: Maja-Theresa Dieterlen, et al.
出版: (2021-08-01)

Feasibility, long‐term safety and immune monitoring of regulatory T cell therapy in living donor kidney transplant recipients
由: Harden, PN, et al.
出版: (2020)

Regulatory immune cells in transplantation.
由: Wood, K, et al.
出版: (2012)

When to refer adult patients with congenital heart disease for transplantation: Which criteria to use, which work-up?
由: Alexander Van De Bruaene, et al.
出版: (2021-08-01)

The where and when of T cell regulation in transplantation.
由: Issa, F, et al.
出版: (2013)

The where and when of T cell regulation in transplantation
由: Issa, F, et al.
出版: (2013)

Identification, selection, and expansion of non-gene modified alloantigen-reactive Tregs for clinical therapeutic use
由: Alzhrani, A, et al.
出版: (2020)

Regulatory B cells in transplantation: roadmaps to clinic
由: Beckett, J, et al.
出版: (2020)

Comprehensive Immune Monitoring of Clinical Trials to Advance Human Immunotherapy
由: Felix J. Hartmann, et al.
出版: (2019-07-01)

DIGITAL PMMA, WHEN AND WHICH
由: Andreea Mariana Bănățeanu, et al.
出版: (2024-12-01)

Cytomegalovirus (CMV) immune monitoring with ELISPOT and QuantiFERON-CMV assay in seropositive kidney transplant recipients.
由: Hyeyoung Lee, et al.
出版: (2017-01-01)

Diagnostic utility of monitoring cytomegalovirus-specific immunity by QuantiFERON-cytomegalovirus assay in kidney transplant recipients
由: Dominika Deborska-Materkowska, et al.
出版: (2018-04-01)

Deciphering the contribution of γδ T cells to outcomes in transplantation
由: McCallion, O, et al.
出版: (2018)

The Exacerbation of Chronic Obstructive Pulmonary Disease: Which Symptom is Most Important to Monitor?
由: Jacobson PK, et al.
出版: (2023-07-01)

A CRISPR-based assay for the detection of opportunistic infections post-transplantation and for the monitoring of transplant rejection
由: Kaminski, Michael M., et al.
出版: (2020)

Evaluation of Minitubers Yield and Scaling which Produced from Microtubers Transplanting Using Soilless Culture Technique
由: Falah Hassan Issa
出版: (2017-06-01)

Cerebrovascular neuroimaging: Which tests and when?
由: Michael Hoffmann
出版: (1996-09-01)

Chimeric antigen receptors and regulatory T cells: the potential for HLA-specific immunosuppression in transplantation
由: Wright, S, et al.
出版: (2021)

Opportunities for high-plex spatial transcriptomics in solid organ transplantation
由: Cross, AR, et al.
出版: (2023)

Which choice of therapy when many are available? Current systemic therapies for advanced hepatocellular carcinoma
由: Nicola Personeni, et al.
出版: (2020-03-01)

Towards regulatory cellular therapies in solid organ transplantation
由: Bottomley, MJ, et al.
出版: (2021)

Late treatment with autologous expanded regulatory T-cell therapy after alemtuzumab induction is safe and facilitates immunosuppression minimization in living donor renal transplantation
由: Brook, MO, et al.
出版: (2024)

Infections in transplant “Bugs which bug transplantation in India”
由: Manisha Sahay
出版: (2017-01-01)

What moves where when in which languages?
由: Richards, Norvin W. (Norvin Waldemar), 1971-
出版: (2008)

Investigations in West Syndrome: Which, When and Why
由: Richard E Appleton
出版: (2015-06-01)

Characterising the immune response to combined skin and solid organ transplants
由: Stark, H
出版: (2022)

Editorial: Personalized nutrition with polyphenols—which, for whom, when and how?
由: Antje R. Weseler, et al.
出版: (2023-05-01)

IL‐33 drives the production of mouse regulatory T cells with enhanced in vivo suppressive activity in skin transplantation
由: Kawai, K, et al.
出版: (2020)

Conversion to sirolimus in kidney transplant recipients with squamous cell cancer and changes in immune phenotype.
由: Carroll, R, et al.
出版: (2013)

Imaging the cellular components of the immune system for advancing diagnosis and immunotherapy of cancers
由: K. Bhise, et al.
出版: (2021-06-01)

Extracorporial Knots in Laparoscopic Surgery: Which, When, and How
由: Omar Salem Khattab
出版: (2008-10-01)

Alternatives to norepinephrine in septic shock: Which agents and when?
由: Mathieu Jozwiak
出版: (2022-10-01)

Which Test to Perform for Cystic hydatic Diagnosis and When?
由: Zahra Arab-Mazar, et al.
出版: (2020-06-01)

When will European Muslim population be majority and in which country?
由: Pierre Rostan, et al.
出版: (2020-09-01)

Stent for Crohn’s disease strictures: Which one and when?
由: Alain Attar
出版: (2016-03-01)

Blood component therapy: Which, when and how much
由: Rajesh Chand Arya, et al.
出版: (2011-01-01)